Author

Steven L Turnball

Active Motif (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Adam R. BrentnalliD· 1 shared Christos N. VelanisiD· 1 shared Daniel Maurice BerneyiD· 1 shared Dong LiniD· 1 shared Edwina Burke· 1 shared Elena JachettiiD· 1 shared Francesco CreaiD· 1 shared George Bryant· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adam R. BrentnallORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacological targeting of EED is an effective therapeutic strategy in cellular models of incurable neuroendocrine prostate cancer

Kayleigh J. A. Orchard, George Bryant, Maryam Latarani, Isabel R Misir, Satyanarayana M Yerra, Christos N. Velanis, Marta Banchi, Irene Fischetti, Steven L Turnball, Mark Eccleston, Theresa Kathleen Kelly, Edwina Burke, Zoe R. Maylin, Guido Bocci, Jonathan Shamash, , Francesco Crea

This study compares tazemetostat and ORIC-944 in NEPC and PRAD cells, finding ORIC-944 more effective in inducing apoptosis and growth inhibition.

bioRxiv · Feb 25, 2026 · PreprintCancer Biology